HEU outcomes: population-evaluation and screening strategies (HOPE)
HEU 结果:人群评估和筛查策略 (HOPE)
基本信息
- 批准号:10645291
- 负责人:
- 金额:$ 66.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-07 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdolescenceAdolescentAdultAdult ChildrenAffectAfrica South of the SaharaAgeAnti-Retroviral AgentsAnxietyAssessment toolAttention deficit hyperactivity disorderBiological MarkersBloodBrain imagingCaringChildClinicClinical DataCognitiveCollaborationsCommunitiesComplementComputerized Medical RecordCost AnalysisDataDepression and SuicideDevelopmentDiagnosticEarly InterventionEducational workshopEnrollmentEpidemiologyEvaluationExposure toFutureGeneral PopulationGrowthGuidelinesHIVHIV antiretroviralHIV-exposed uninfected infantHealthHearingIncomeIndividualInfantInfectionInflammationInterventionKenyaLengthLinkLongitudinal StudiesLongitudinal cohortMedicalMedical RecordsMental DepressionMental HealthMonitorMorbidity - disease rateMother-to-child HIV transmissionMothersNeurodevelopmental DeficitOutcomePerformancePerinatalPersonsPharmaceutical PreparationsPhasePoliciesPopulationPregnancyPreventionPublic HealthRegimenRiskSampling StudiesScreening procedureSiteSpottingsSurveysSystemTreatment ProtocolsViral Load resultWomanWorkadverse outcomeagedautism spectrum disorderbaseclinically relevantcofactorcohortcost estimatedesigndiagnostic toolefavirenzepidemiology studyexperiencefetalfollow-uphealth assessmentimaging studyinfancyinsightmortalityneurodevelopmentnovel strategiesopen sourcepilot testpopulation basedprenatal exposurepreventprogramsrecruitrural settingscreeningscreening programtelomeretooltreatment guidelinesurban setting
项目摘要
ABSTRACT
There is a substantial and growing population of children/adolescents who are HIV exposed uninfected (HEU)
in sub-Saharan Africa (SSA). There is emerging evidence that fetal exposure to maternal infections and
medications may result in adverse adult/adolescent mental health outcomes; it is plausible that fetal exposure to
HIV or antiretrovirals (ART) could similarly influence long-term outcomes. Despite evidence for poor growth
and neurodevelopmental deficits, programs to systematically monitor neurodevelopmental and mental
health outcomes among HEU at a population level are lacking. Understanding whether there are increased
adverse neurodevelopmental and mental health outcomes in HEU due to fetal HIV/ART exposure has been
challenged by difficulties in defining appropriate comparator cohorts, changing PMTCT treatment guidelines, and
lack of validated, scale-able assessment tools.
Our team has a unique track record for moving novel approaches for screening and testing from pilot to
implementation, conducting large scale evaluations, and conducting neurodevelopmental and mental health
assessments in HIV-affected children and adolescents. We propose parallel longitudinal and population
based HEU/HUU cohorts, in urban and rural settings, spanning infants/children/adolescents age 6 weeks
to 18 years to determine differences in neurodevelopmental and mental health outcomes. The R61 phase
will accrue a longitudinal homogenous cohort of 2000 HEU/HUU infants exposed to Option B+ PMTCT treatment
regimens, with extended follow-up in the R33 phase for a total of for 4 years, and assessed for
neurodevelopmental, mental health, hearing, growth outcomes and telomere length. An approach to survey older
HEU/HUU (age 3-18) for neurodevelopmental and mental health outcomes and collect maternal medical, ART
regimen and timing, and viral load data from medical records will be piloted in the R61 phase and expanded to
100 HIV clinics in the R33 phase. Selected neurodevelopmental/mental health screening and diagnostic tools to
be used are based on open source availability, diagnostic or screening performance, cultural appropriateness,
accessibility, and clinical relevance. In the national R33 survey, cost analysis will complement clinical data; and
together, will be disseminated to stakeholders at a workshop to develop a framework for an integrated HEU
screening program in public health settings.
This proposal leverages extensive team experience in prior longitudinal MTCT cohorts, in national child and
adolescent surveys, HEU recruitment, neurodevelopmental and mental health assessment, and medical record
extraction and analysis at scale, to comprehensively understand burden, mechanism and outcomes in HEU.
Engaging stakeholders has the potential to enhance HEU management programmatically based on findings.
抽象的
有大量未感染艾滋病毒的儿童/青少年 (HEU),而且数量还在不断增加
撒哈拉以南非洲 (SSA)。越来越多的证据表明,胎儿接触母体感染和
药物可能会导致成人/青少年心理健康不良结果;胎儿暴露于
HIV 或抗逆转录病毒药物 (ART) 可能同样影响长期结果。尽管有证据表明增长不佳
和神经发育缺陷,系统监测神经发育和心理的计划
HEU 在人口层面上的健康结果缺乏。了解是否增加
胎儿 HIV/ART 暴露导致 HEU 神经发育和心理健康不良结果已被证实
面临着难以确定适当的比较队列、改变预防母婴传播治疗指南的挑战,以及
缺乏经过验证的、可扩展的评估工具。
我们的团队在将筛选和测试的新颖方法从试点转移到
实施、进行大规模评估以及进行神经发育和心理健康
对受艾滋病毒影响的儿童和青少年进行评估。我们提出平行纵向和总体
基于 HEU/HUU 队列,在城市和农村环境中,涵盖 6 周龄的婴儿/儿童/青少年
至 18 岁,以确定神经发育和心理健康结果的差异。 R61相
将产生一个由 2000 名接受选项 B+ PMTCT 治疗的 HEU/HUU 婴儿组成的纵向同质队列
方案,在 R33 阶段进行总共 4 年的延长随访,并评估
神经发育、心理健康、听力、生长结果和端粒长度。调查老年人的方法
HEU/HUU(3-18 岁)用于神经发育和心理健康结果并收集孕产妇医疗、ART
治疗方案和时间安排以及病历中的病毒载量数据将在 R61 阶段进行试点,并扩展到
R33 阶段有 100 个 HIV 诊所。精选的神经发育/心理健康筛查和诊断工具
使用基于开源可用性、诊断或筛查性能、文化适宜性、
可及性和临床相关性。在国家R33调查中,成本分析将补充临床数据;和
将在研讨会上向利益相关者传播,以制定综合高浓铀框架
公共卫生机构的筛查计划。
该提案利用了先前纵向 MTCT 队列、全国儿童和儿童群体中的丰富团队经验。
青少年调查、HEU 招募、神经发育和心理健康评估以及医疗记录
大规模提取和分析,全面了解高浓铀的负担、机制和结果。
利益相关者的参与有可能根据调查结果有计划地加强高浓铀管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Grace John-Stewart其他文献
Grace John-Stewart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Grace John-Stewart', 18)}}的其他基金
Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection
HIV感染儿童出生和神经发育结果的药物、微生物组和免疫决定因素
- 批准号:
10381032 - 财政年份:2022
- 资助金额:
$ 66.35万 - 项目类别:
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes
以数据为依据的分级护理 (DiSC) 可改善青少年艾滋病毒治疗结果
- 批准号:
10579767 - 财政年份:2022
- 资助金额:
$ 66.35万 - 项目类别:
HEU outcomes: population-evaluation and screening strategies (HOPE)
HEU 结果:人群评估和筛查策略 (HOPE)
- 批准号:
10661848 - 财政年份:2020
- 资助金额:
$ 66.35万 - 项目类别:
HEU outcomes: population-evaluation and screening strategies (HOPE)
HEU 结果:人群评估和筛查策略 (HOPE)
- 批准号:
10063773 - 财政年份:2020
- 资助金额:
$ 66.35万 - 项目类别:
HEU outcomes: population-evaluation and screening strategies (HOPE)
HEU 结果:人群评估和筛查策略 (HOPE)
- 批准号:
10764153 - 财政年份:2020
- 资助金额:
$ 66.35万 - 项目类别:
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes
以数据为依据的分级护理 (DiSC) 可改善青少年艾滋病毒治疗结果
- 批准号:
10252949 - 财政年份:2018
- 资助金额:
$ 66.35万 - 项目类别:
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes
以数据为依据的分级护理 (DiSC) 可改善青少年艾滋病毒治疗结果
- 批准号:
10227279 - 财政年份:2018
- 资助金额:
$ 66.35万 - 项目类别:
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes
以数据为依据的分级护理 (DiSC) 可改善青少年艾滋病毒治疗结果
- 批准号:
9923276 - 财政年份:2018
- 资助金额:
$ 66.35万 - 项目类别:
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes
以数据为依据的分级护理 (DiSC) 可改善青少年艾滋病毒治疗结果
- 批准号:
10468750 - 财政年份:2018
- 资助金额:
$ 66.35万 - 项目类别:
相似海外基金
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
- 批准号:
10755168 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
- 批准号:
480840 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
- 批准号:
10744412 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
- 批准号:
23K07305 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
- 批准号:
23H02874 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
- 批准号:
10756652 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
- 批准号:
10730872 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
- 批准号:
10650648 - 财政年份:2023
- 资助金额:
$ 66.35万 - 项目类别: